Netherlands Neurology Clinical Trials Market Analysis

Netherlands Neurology Clinical Trials Market Analysis


$ 3999

Netherlands's Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the modern healthcare infrastructure and an innovative & collaborative research environment. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Netherlands BV, Roche Holding AG & Johnson & Johnson.

ID: IN10NLCT005 CATEGORY: Clinical Trials GEOGRAPHY: Netherlands AUTHOR: Vidhi Upadhyay

Buy Now

Netherlands Neurology Clinical Trials Market Executive Summary

Netherlands's Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. Alzheimer's and dementia fatalities in the Netherlands reached 18,148 in 2020, accounting for 14.31% of total deaths, based on the most recent WHO statistics. The Netherlands ranks seventh in the world with an age-adjusted death rate of 33.78 per 100,000 inhabitants. There are around 120,000 individuals in the Netherlands who have active epilepsy.

The Netherlands has a reasonably robust neurology clinical trials market owing to the country's well-established healthcare system, research infrastructure, and supportive regulatory environment. The Netherlands has a long history of excelling in medical research, notably in the area of neuroscience, and it is home to many world-class university medical institutes such as Amsterdam University Medical Centers, Radboud University Medical Center & University Medical Center Groningen that perform clinical trials in the subject. Moreover, companies such as Biogen, UCB, Janssen & AbbVie have also been keen on performing clinical trials in the Netherlands.

The nation also has a well-developed clinical research regulatory system, including the Central Council on Research Involving Human Subjects (CCMO), which monitors clinical trials involving human volunteers. The CCMO guarantees that clinical trials in the Netherlands are ethical, transparent, and under national and international legislation.

Netherlands Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The Netherlands has been an active participant in neurology clinical trials. The modern healthcare infrastructure, along with an innovative research environment, is one of the major drivers of the country's rise in neurology clinical trials. The country's healthcare system is well-known for providing high-quality treatment and efficient administration. The nation also has a well-developed clinical research regulatory structure, including the Central Council on Research Involving Human Subjects (CCMO), which regulates clinical trials with human subjects.

Moreover, the Netherlands has an extensive network of academic universities and research organizations dedicated to neurological research. This network facilitates cooperation among researchers, physicians, and industry partners, creating an environment favorable to the development of innovative treatments and therapies for neurological illnesses.

Market Restraints

there are a number of constraints that might limit the expansion of neurology clinical trials in the Netherlands. The rising complexity and expense of clinical trials are one of the most critical issues. Clinical trials for neurological illnesses sometimes need a large number of patients and sophisticated research designs, making them costly to undertake. This may restrict the number of studies that may be carried out in the Netherlands, particularly for smaller enterprises or academic institutions with little finance. Another difficulty is growing competition from other nations, notably those in Eastern Europe and Asia, which are drawing more clinical trials due to cheaper prices and less severe regulations. Competitiveness may result in fewer clinical trials being done in the Netherlands, limiting the country's ability to contribute to the discovery of innovative therapies for neurological illnesses.

Competitive Landscape

Key Players

  • Biogen Netherlands BV
  • Roche Holding AG
  • Pfizer Inc.
  • Novartis AG
  • Janssen Pharmaceutical (Johnson & Johnson)
  • UCB Pharma B.V.  (NLD)
  • AstraZeneca plc
  • ICON plc
  • CHDR (Centre for Human Drug Research)

Notable Deals

January 2023, The FDA approved Eisai, a Biogen Alzheimer's drug.

Healthcare Policies and Regulatory Landscape

The Netherlands has completely adopted the EU Clinical Trials Directive (CTD). An identical Clinical Trial Application (CTA) document must be submitted in tandem with an authorized Ethics Committee and the Centrale Commissie Mensgebonden Onderzoek (CCMO=Competent Authority) before the start of a clinical study. The research may begin after the Ethics Committee has given its approval and the Competent Authority has issued a declaration of no objection.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 December 2023
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up